Muzhou Teng

Muzhou Teng

Auto-generated profile, based on publicly available information

Muzhou Teng

Key Laboratory of Maternal‐Fetal Medicine and Reproductive Protection of Gansu Province, Gansu Provincial Maternity and Child‐Care Hospital (Gansu Provincial Central Hospital) Lanzhou China

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 June 2024 in Aggregate
Verified
Journal Article
Open access
YXYouqin Xu
Youqin Xu
YXYili Xie
Yili Xie
QWQing Wan
Qing Wan
JTJianwen Tian
Jianwen Tian
JLJing Liang
Jing Liang
MTMuzhou Teng
Muzhou Teng
Type I photosensitizers (PSs) with the ability to generate reactive oxygen species (ROS) containing superoxide anion and hydroxyl radical have promising application potential for treating hypoxia tumors, but the deep mechanism of type II ROS converts to the type I ROS in the PSs is still unclear, it is urgent to reveal influencing factors about inducing type I ROS generation. Herein, six PSs with aggregation‐induced emission properties, which were fabricated with the same electronic acceptor but different electronic donors and “π‐bridge”, have been successfully prepared to explore the influencing mechanism of generating superoxide anion and hydroxyl radical from organic PSs. Experimental results discovered two factors containing molecular structure and aggregated environment could decide the ROS efficiency and types of PSs. On the level of designing molecular structure, we discovered that “π‐bridge” with a lower energy level of the lowest triplet state could be beneficial for triggering the production of superoxide anion, and electronic donor of triphenylamine was an important factor in producing hydroxyl radical than another donor of dimethylamine. On the level of designing aggregates of PS‐based polymeric nanoparticles, bovine serum albumin could improve largely the generation efficiency of superoxide anion. Due to the satisfactory ROS efficiency and better biocompatibility, synthetic PSs showed excellent photodynamic therapy outcomes in vitro/vivo.

8 February 2023 in Chemical Engineering Journal
Verified
Journal Article
Closed access
MTMuzhou Teng
Muzhou Teng
JTJialin Tong
Jialin Tong
YXYili Xie
Yili Xie
YLYumin Li
Yumin Li
ZLZhijia Li
Zhijia Li
TLTao Liu
Tao Liu

25 April 2024 in RSC Advances
Verified
Journal Article
Open access
PDF file
ZLZhiyong Li
Zhiyong Li
YXYili Xie
Yili Xie
HLHeng Liu
Heng Liu
JWJing Wang
Jing Wang
GWGang Wang
Gang Wang
MTMuzhou Teng
Muzhou Teng
Near-infrared red (NIR) fluorescence imaging guide phototherapeutic therapy (PDT) has the advantages of deep tissue penetration, real-time monitoring of drug treatment and disease, little damage to normal tissue, low cytotoxicity and almost no side effects, and thus, it is attracting increasing research attention and is expected to show promising potential for clinical tumor treatment. The photosensitizer (PS), light source and oxygen are the three basic and important factors to construct PDT technology, and highly efficient PSs are still being passionately pursued because they determine the PDT efficiency. Ideal PSs should have properties such as good biocompatibility, deep tissue penetration, and highly efficient reactive oxygen species (ROS) generation despite the hypoxic environment. Therefore, pure organic type I PSs with NIR fluorescence have been receiving increasing attention due to their deep penetration and hypoxia resistance. However, reported NIR-active type I PSs usually require complex synthetic procedures, which presents a challenge for mass production. In this research work, based on the molecular design ideas of introducing the heavy atom effect and intramolecular charge transfer, we prepared three NIR-active type I PSs (TNZ, TNZBr, and TNZCHO) using a very simple method with one or two synthetic steps. Clear characterizations of photophysical properties, ROS performance tests, and fluorescent imaging of human umbilical vein endothelial (HUVE) cells and PDT treatment of HepG2 cells were carried out. The results revealed that the heavy atom and intramolecular charge transfer (ICT) effects could obviously enhance the ROS efficiency, and both PSs produce only type I ROS without any type II ROS (1O2) generation. The good NIR fluorescence brightness and type I ROS efficiency ensure satisfactory bioimaging and PDT outcomes. This research provides the possibility of preparing NIR-active type I PSs via mass production.

7 February 2023 in Bioconjugate Chemistry
Verified
Journal Article
Closed access
MTMuzhou Teng
Muzhou Teng
ZLZhijia Li
Zhijia Li
YZYali Zhou
Yali Zhou
ZZZhengchao Zhang
Zhengchao Zhang
LMLele Miao
Lele Miao
SWSong Wang
Song Wang

12 September 2025 in Luminescence
Verified
Journal Article
Closed access
JFJie Fu
Jie Fu
YFYong Fan
Yong Fan
YLYongyong Liu
Yongyong Liu
BKBoxiong Kang
Boxiong Kang
QWQiuya Wei
Qiuya Wei
MTMuzhou Teng
Muzhou Teng